Programme 04

Cost Optimisation — value, safely realised.

Prescribing efficiency, deprescribing where appropriate, and formulary-aligned switches — savings reported per PCN and per ICB priority.

What we target

Where the savings come from.

  • Therapeutic switches aligned to local formulary
  • Generic vs brand opportunities
  • Wastage and over-ordering reduction
  • Polypharmacy deprescribing
  • Specialist drug reviews
  • Repeat prescribing quantity and synchronisation

How we work

Savings, safely realised.

  • ICB and PCN priorities mapped before any switch is proposed
  • Patient-by-patient clinical review — never a blanket switch
  • GP sign-off on every change
  • Patient comms drafted and sent by BCS, not added to GP workload
  • Post-switch monitoring built into the BCS Impact Dashboard

Typical first-year outcomes

Measured monthly and reported to your PCN.

£6–£12
Saved per patient on caseload
100%
Switches with GP sign-off
Medicines wastage
0
Patient-safety incidents from switches

DES 26/27 alignment

Tied to the Network Contract DES.

Cost optimisation work is fully aligned to the medicines optimisation requirements of the Network Contract DES, IIF prescribing indicators, and local ICB formulary positions. Every saving is auditable and CQC-ready.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call